Northern Trust
WHWK

Northern Trust’s Whitehawk Therapeutics WHWK Stock Holding History

Northern Trust’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
264,689
+157,423
+147% +$655K ﹤0.01% 3390
2026
Q1 		$370K Buy
107,266
+3,814
+4% +$11.9K ﹤0.01% 3727
2025
Q4 		$250K Buy
103,452
+31,288
+43% +$71.8K ﹤0.01% 3900
2025
Q3 		$137K Sell
72,164
-20,111
-22% -$37K ﹤0.01% 4066
2025
Q2 		$173K Buy
92,275
+5,952
+7% +$10.4K ﹤0.01% 3987
2025
Q1 		$154K Sell
86,323
-4,828
-5% -$12.6K ﹤0.01% 4011
2024
Q4 		$288K Buy
91,151
+22,677
+33% +$51.4K ﹤0.01% 3860
2024
Q3 		$141K Sell
68,474
-90,206
-57% -$146K ﹤0.01% 3977
2024
Q2 		$232K Sell
158,680
-124
-0.1% -$230 ﹤0.01% 3814
2024
Q1 		$372K Sell
158,804
-3,559
-2% -$6.86K ﹤0.01% 3659
2023
Q4 		$328K Buy
162,363
+21,215
+15% +$89K ﹤0.01% 3692
2023
Q3 		$683K Buy
141,148
+12,825
+10% +$74.5K ﹤0.01% 3426
2023
Q2 		$878K Buy
128,323
+7,992
+7% +$62.1K ﹤0.01% 3412
2023
Q1 		$871K Sell
120,331
-2,174
-2% -$23.2K ﹤0.01% 3270
2022
Q4 		$1.57M Sell
122,505
-3,861
-3% -$50.4K ﹤0.01% 3111
2022
Q3 		$1.79M Sell
126,366
-7,858
-6% -$103K ﹤0.01% 3071
2022
Q2 		$1.65M Buy
134,224
+97,966
+270% +$1.46M ﹤0.01% 3160
2022
Q1 		$615K Sell
36,258
-550
-1% -$10.5K ﹤0.01% 3656
2021
Q4 		$889K Buy
+36,808
New +$924K ﹤0.01% 3590
2021
Q3 		– Sell
-3,707
Closed -$94K – 4756
2021
Q2 		$94K Hold
3,707
– – ﹤0.01% 4377
2021
Q1 		$72K Hold
3,707
– – ﹤0.01% 4338
2020
Q4 		$54K Sell
3,707
-63
-2% -$1.35K ﹤0.01% 4228
2020
Q3 		$85K Buy
3,770
+423
+13% +$8.9K ﹤0.01% 3999
2020
Q2 		$63K Sell
3,347
-171
-5% -$2.24K ﹤0.01% 4015
2020
Q1 		$29K Hold
3,518
– – ﹤0.01% 4036
2019
Q4 		$33K Hold
3,518
– – ﹤0.01% 4101
2019
Q3 		$36K Hold
3,518
– – ﹤0.01% 4090
2019
Q2 		$48K Hold
3,518
– – ﹤0.01% 4088
2019
Q1 		$48K Buy
+3,518
New +$151K ﹤0.01% 4045

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust's WHWK Position: Q2 2026 in Review

Northern Trust increased its Whitehawk Therapeutics (WHWK) stake by 147% in Q2 2026, buying an estimated $655K and bringing the position to 264,689 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3390.

Northern Trust first reported a position in WHWK in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.79M in Q3 2022. 77 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Northern Trust held 264,689 shares of Whitehawk Therapeutics worth $1.21M as of Q2 2026.
  • Northern Trust bought 157,423 Whitehawk Therapeutics shares in Q2 2026, an estimated $655K.
  • Whitehawk Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3390 holding.
  • Northern Trust first reported a position in Whitehawk Therapeutics in Q1 2019 and has held it in 29 quarters since.
  • Northern Trust's Whitehawk Therapeutics position peaked at $1.79M in Q3 2022.
  • 77 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.